C3J Therapeutics

C3J Therapeutics is a clinical-stage biotechnology company dedicated to the development and promotion of targeted antimicrobial drugs for the prevention and treatment of pathogens and the reduction of the likelihood of secondary infections. The company focuses on leveraging its STAMP platform technology to develop various specific targeted antimicrobial peptides, a new type of antimicrobial drug, driving the advancement of the "New Antibiotic Era."